EHRA Premium Access

Distilling the clinical evidence behind the WCD - What have clinical trials and registries told us?

Congress Session

About the speaker

Doctor Sebastian Reif

Munich Clinic Bogenhausen, Munich (Germany)
1 presentation
0 follower

4 more presentations in this session

Introduction - Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death.

Speaker: Doctor G. Botto (Garbagnate Milanese, IT)

Thumbnail

Strategies for screening and identifying which patients to protect with the WCD.

Speaker: Professor J. Ehrlich (Wiesbaden, DE)

Thumbnail

The impact of the WCD for patients who choose to wear it.

Speaker: Professor D. Scherr (Graz, AT)

Thumbnail

Panel discussion and summary - Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death.

Speaker: Doctor O. Piot (Saint Denis, FR)

Thumbnail

Access the full session

Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death

Speakers: Doctor S. Reif, Doctor G. Botto, Professor J. Ehrlich, Professor D. Scherr, Doctor O. Piot
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk